Lv61
1680 积分 2023-06-20 加入
The present and future of bispecific antibodies for cancer therapy
16分钟前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
4天前
已完结
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
4天前
已完结
The use of anabolic agents in the treatment of osteoporosis: a clinical update
5天前
已完结
Capivasertib: First Approval
6天前
已完结
Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society
10天前
已完结
ADRIATIC: When face value is enough
11天前
已关闭
The first Chinese National Union of Real‐world Gynaecological Oncology Research and Patient Management Platform: A retrospective study
1个月前
已完结
Epidemiology of PNH and Real-World Treatment Patterns Following an Incident PNH Diagnosis in the US
1个月前
已关闭
Epidemiology of PNH and Real-World Treatment Patterns Following an Incident PNH Diagnosis in the US
1个月前
已关闭
皖公网安备34019202002308
